ARCHIVES

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

This article is from The Cancer Letter archive.

Vol. 26 No. 6 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Epstein Petition Seeks Broder’s Removal As NCI Director

February 5, 1993

In Brief: Allegra To Head NCI/Navy Branch; Sausville Promoted; Gladstein To Leave NCI For Dallas

October 25, 1991

Resource Offered for DNA Probe Mapping

August 14, 1987

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

March 5, 1993

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014

Radiation Improves Survival In Advanced Prostate Cancer

June 25, 2010